Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS Research and Interventions, Complement system in diseases, and HIV/AIDS drug development and treatment.
Academia Europaea’s guidelines for the visualization of clinical outcomes
Treatment discontinuation in adults with atypical hemolytic uremic syndrome (aHUS): a qualitative study of international experts’ perspectives with associated cost-consequence analysis
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Tissue factor upregulation is associated with SARS‐CoV‐2 in the lungs of COVID‐19 patients
The skin as a critical window in unveiling the pathophysiologic principles of COVID-19
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
Severe COVID-19: A multifaceted viral vasculopathy syndrome
The differing pathophysiologies that underlie COVID‐19‐associated perniosis and thrombotic retiform purpura: a case series
Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?
Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis
Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
PubMed 2016cited by 89position: first
The role of complement activation in thrombosis and hemolytic anemias
Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
PubMed 2012cited by 74position: first